| Date | Time | Source | Headline | Symbol | Company |
| 06/02/2024 | 2:08AM | PR Newswire (Canada) | Ontario Lottery and Gaming Corporation - EVENING LOTTERY WINNING NUMBERS - June 1, 2024 | | |
| 06/02/2024 | 2:00AM | GlobeNewswire Inc. | ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth | | |
| 06/02/2024 | 2:00AM | GlobeNewswire Inc. | ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth | | |
| 06/01/2024 | 11:56PM | PR Newswire (US) | Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC | | |
| 06/01/2024 | 11:30PM | PR Newswire (Canada) | 'A Red Cross for Journalism': Committee to Protect Journalists awarded Canadian Association of Journalists' 2024 Charles Bury Award | | |
| 06/01/2024 | 11:30PM | PR Newswire (Canada) | « Une Croix-Rouge pour le journalisme » : Le Comité de protection des journalistes reçoit le prix Charles Bury 2024 de l'Association canadienne des journalistes | | |
| 06/01/2024 | 11:30PM | PR Newswire (Canada) | L'Association canadienne des journalistes honore l'excellence du journalisme canadien de l'année écoulée lors de son gala annuel de remise de prix | | |
| 06/01/2024 | 11:30PM | PR Newswire (Canada) | Canadian Association of Journalists celebrates excellence in Canadian journalism from the past year at annual awards gala | | |
| 06/01/2024 | 8:25PM | PR Newswire (US) | Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO | | |
| 06/01/2024 | 8:17PM | PR Newswire (US) | CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC | | |
| 06/01/2024 | 8:15PM | GlobeNewswire Inc. | Heineken® Celebrates Thousands of ‘Real Hardcore Fans’ by Helping Them Take Part in the UEFA Champions League Final Trophy Celebrations For The First Time Ever | | |
| 06/01/2024 | 7:13PM | PR Newswire (US) | GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO A | | |
| 06/01/2024 | 6:09PM | PR Newswire (US) | LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI® | | |
| 06/01/2024 | 6:06PM | PR Newswire (US) | NAISMA Announces PlayCleanGo® Awareness Week 2024: Real People, Real Stories | | |
| 06/01/2024 | 5:52PM | PR Newswire (US) | Sun Bum Makes SPF Waves in Miami with its Largest Ever Beach Hangout for Skin Cancer Awareness Month | | |
| 06/01/2024 | 5:18PM | PR Newswire (Canada) | Avis aux médias - Itinéraire de la vice-première ministre pour le dimanche 2 juin 2024 | | |
| 06/01/2024 | 5:10PM | GlobeNewswire Inc. | National Skills Champions are Honoured at the Skills Canada National Competition 2024, in Québec | | |
| 06/01/2024 | 5:10PM | PR Newswire (Canada) | Media Advisory - Deputy Prime Minister's itinerary for Sunday, June 2, 2024 | | |
| 06/01/2024 | 5:00PM | PR Newswire (Canada) | Media Advisory - Prime Minister's itinerary for Sunday, June 2, 2024 | | |
| 06/01/2024 | 5:00PM | PR Newswire (Canada) | Avis aux médias - Itinéraire du premier ministre pour le dimanche 2 juin 2024 | | |
| 06/01/2024 | 4:30PM | PR Newswire (US) | Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation | | |
| 06/01/2024 | 3:42PM | Business Wire | Bihar collabora con Bidgely per ridurre i furti di energia e le perdite di ricavi tramite l'analisi dei dati alimentata dall'IA | | |
| 06/01/2024 | 3:40PM | PR Newswire (US) | BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025 | | |
| 06/01/2024 | 3:00PM | GlobeNewswire Inc. | First Federal Savings Bank and ICBA Offer Tips to Help Simplify the Homebuying Process | | |
| 06/01/2024 | 3:00PM | PR Newswire (US) | Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting | | |
| 06/01/2024 | 2:42PM | Business Wire | Accutar Biotechnology、ASCO 2024にてER +/ HER2-乳がん患者におけるAC699単剤療法の第1相試験データを発表 | | |
| 06/01/2024 | 2:25PM | Business Wire | New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate) | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 06/01/2024 | 2:20PM | Business Wire | Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024 | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 06/01/2024 | 2:08PM | PR Newswire (US) | Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US | | |
| 06/01/2024 | 2:00PM | PR Newswire (Canada) | Le gouvernement du Québec dévoile les résultats de la consultation sur la mobilité dans les régions de la Capitale-Nationale et de la Chaudière-Appalaches | | |